Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged 70 Years, from the ATHENA Study Evaluating First-Line Bevacizumab-Containing Therapy for Locally Recurrent/Metastatic Breast Cancer

被引：0

作者：

Pritchard, K. I.

Thomssen, C.

Pierga, J-Y

Cortes-Funes, H.

Biganzoli, L.

Guan, Z.

Manikhas, G.

Jendiroba, D.

Uziely, B.

Boyle, F.

Jagiello-Gruszfeld, A.

Van Arkel, C.

Tung, Y.

Dunne, A-A

Smith, I. E.

机构：

[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada

[2] Univ Halle Wittenberg, D-06108 Halle, Saale, Germany

[3] Univ Paris 05, Inst Curie, Paris, France

[4] Hosp Univ 12 Octubre, Madrid, Spain

[5] Prato Hosp, Ist Toscano Tumori, Prato, Italy

[6] Sun Yat Sen Univ Med Sci, Guangzhou, Guangdong, Peoples R China

[7] St Petersburg City Oncol Hosp, St Petersburg, Russia

[8] Ctr Goiano Oncol, Goiania, Go, Brazil

[9] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel

[10] Mater Private Hosp, Sydney, NSW, Australia

[11] Mazowiecki Szpital Onkol, Wieliszew, Poland

[12] Slingeland Ziekenhuis Inwendige Geneeskunde, Doetinchem, Netherlands

[13] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China

[14] F Hoffmann La Roche Ltd, Basel, Switzerland

[15] Royal Marsden Hosp, London SW3 6JJ, England

[16] Inst Canc Res, London SW3 6JB, England

来源：

关键词：

D O I：

10.1158/0008-5472.SABCS10-P2-16-06

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2-16-06

引用

页数：1